Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $147.47 USD
Change Today +0.87 / 0.59%
Volume 203.8K
ILMN On Other Exchanges
As of 10:34 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ILLUMINA INC (ILMN) in the last 6 months

Announced 08/18/15
Private Placement

Helix announced that it has received a round of funding on August 18, 2015. The transaction included participation from new investors Illumina Inc., Warburg Pincus LLC, and Sutter Hill Ventures for more than $100 million and Mayo Clinic. As part of the transaction, Jay Flatley, Chief Executive Officer of Illumina Inc. joined as the chairman of board of directors of the company. Robert Langdon, Juliana Capata, Colin Lloyd, Lori Lesser, Genevieve Dorment, Katharine ...
Read More

ILMN's price was unchanged after the transaction was announced on 08/18/15.
Investor / Buyer
Illumina Inc.
Mayo Clinic
Sutter Hill Ventures
Warburg Pincus LLC
Announced 08/4/15
GenoLogics Life Sciences Software, Inc.

Illumina Inc. (NasdaqGS:ILMN) entered into an agreement to acquire remaining stake in GenoLogics Life Sciences Software, Inc. from Yaletown Venture Partners Inc. and others on August 4, 2015. GenoLogics will become part of Illumina Enterprise Informatics business under the leadership of Sanjay Chikarmane, Senior Vice President and General Manager of Enterprise Informatics. The acquisition is expected to close by the end of August 2015.

ILMN's price was unchanged after the transaction was announced on 08/4/15.
Investor / Buyer
Illumina Inc.
Creditor / Lender
OVP Venture Partners
Yaletown Venture Partners Inc.
Announced 07/21/15
150.00M for Illumina Inc.

Illumina Inc. (NasdaqGS:ILMN) announces a share repurchase program. Under the program, the company will repurchase up to $150 million worth of its common stock. The repurchases will be effected via Rule 10b5-1 rule plan. The repurchased shares which will be used to manage dilution from employee grants. The Board of Directors of Illumina Inc. has authorized a buyback plan on May 1, 2015. On May 1, 2015, the company initiated a Market Repurchase. From May 1, 2015 ...
Read More

ILMN's price was unchanged after the transaction was announced on 07/21/15.
Announced 05/29/15
37.00M for Twist Bioscience Corporation
Private Placement

Twist Bioscience Corporation announced that it will receive $36,999,999 in equity funding on May 29, 2015. The company will issue securities pursuant to exemption provided under Regulation D.

ILMN's price was unchanged after the transaction was announced on 05/29/15.
Investor / Buyer
Arch Venture Partners, L.P.
Fidelity Management & Research Company
Foresite Capital Management, LLC
Illumina Inc.
Paladin Capital Group
Tao Invest

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILMN:US $147.47 USD +0.87

ILMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 4,228 INR +40.55
Hologic Inc $37.46 USD -0.16
Sigma-Aldrich Corp $139.60 USD -0.05
Symrise AG €55.34 EUR -1.02
Waters Corp $120.74 USD +0.15
View Industry Companies

Industry Analysis


Industry Average

Valuation ILMN Industry Range
Price/Earnings 45.2x
Price/Sales 10.3x
Price/Book 11.9x
Price/Cash Flow 40.4x
TEV/Sales 9.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at